Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Cryo Cell International (CCEL) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $436588.0.

  • Cryo Cell International's Tax Provisions rose 3303.07% to $436588.0 in Q3 2025 from the same period last year, while for Aug 2025 it was $2.2 million, marking a year-over-year increase of 16552.04%. This contributed to the annual value of $2.7 million for FY2024, which is 17070.32% up from last year.
  • Per Cryo Cell International's latest filing, its Tax Provisions stood at $436588.0 for Q3 2025, which was up 3303.07% from $219318.0 recorded in Q2 2025.
  • Cryo Cell International's Tax Provisions' 5-year high stood at $2.4 million during Q4 2021, with a 5-year trough of -$4.8 million in Q4 2023.
  • For the 5-year period, Cryo Cell International's Tax Provisions averaged around $257207.5, with its median value being $328186.0 (2024).
  • In the last 5 years, Cryo Cell International's Tax Provisions plummeted by 69286.1% in 2023 and then soared by 55082.63% in 2024.
  • Cryo Cell International's Tax Provisions (Quarter) stood at $2.4 million in 2021, then tumbled by 66.23% to $810146.0 in 2022, then tumbled by 692.86% to -$4.8 million in 2023, then soared by 127.78% to $1.3 million in 2024, then plummeted by 67.28% to $436588.0 in 2025.
  • Its Tax Provisions stands at $436588.0 for Q3 2025, versus $219318.0 for Q2 2025 and $250863.0 for Q1 2025.